ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Protalix BioTherapeutics, Inc. (PLX) stock declined over -1.65%, trading at $2.39 on AMEX, down from the previous close of $2.43. The stock opened at $2.45, fluctuating between $2.36 and $2.46 in the recent session.
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso for the treatment of Gaucher disease. Its product pipeline comprises PRX-102, a therapeutic protein candidate, which is in the last stage of clinical trials for the treatment of Fabry diseases; PRX-110, a proprietary plant cell recombinant form of human deoxyribonuclease I that has completed phase IIa clinical trials for the treatment of cystic fibrosis; PRX-115, a plant cell-expressed recombinant PEGylated Uricase for the treatment of gout; and PRX-119, a plant cell-expressed PEGylated recombinant human DNase I product candidate for the treatment of NETs-related diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz (Fiocruz); and Chiesi Farmaceutici S.p.A. The company was founded in 1993 and is based in Hackensack, New Jersey.
Employees | 208 |
Beta | 0.75 |
Sales or Revenue | $65.49M |
5Y Sales Change% | -0.583% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Biotechnology |
Protalix BioTherapeutics, Inc. (AMEX: PLX) stock price is $2.39 in the last trading session. During the trading session, PLX stock reached the peak price of $2.46 while $2.36 was the lowest point it dropped to. The percentage change in PLX stock occurred in the recent session was -1.65% while the dollar amount for the price change in PLX stock was -$0.04.
The AMEX listed PLX is part of Biotechnology industry that operates in the broader Healthcare sector. Protalix BioTherapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Yael Fellous
Vice President of HR
Mr. Yaron Naos
Senior Vice President of Operations
Mr. Dror Bashan
Pres, Chief Executive Officer & Director
Mr. Eyal Rubin M.B.A.
Senior Vice President, Chief Financial Officer, Treasurer & Corporation Sec.
PLX's closing price is 191.46% higher than its 52-week low of $0.82 where as its distance from 52-week high of $2.76 is -13.41%.
Number of PLX employees currently stands at 208.
Official Website of PLX is: https://www.protalix.com
PLX could be contacted at phone 201 696 9345 and can also be accessed through its website. PLX operates from 2 University Plaza, Hackensack, NJ 07601, United States.
PLX stock volume for the day was 536.86K shares. The average number of PLX shares traded daily for last 3 months was 550.54K.
The market value of PLX currently stands at $175.98M with its latest stock price at $2.39 and 73.63M of its shares outstanding.